Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Asthenia and UGT1A1[original query] |
---|
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism. Investigational new drugs 2003 Nov 21 (4): 435-43. Font Albert, Sánchez José Miguel, Tarón Miquel, Martinez-Balibrea Eva, Sánchez José Javier, Manzano José Luis, Margelí Mireia, Richardet Martin, Barnadas Agustí, Abad Albert, Rosell Rafa |
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer. British journal of cancer 2004 Aug 91 (4): 678-82. Marcuello E, Altés A, Menoyo A, Del Rio E, Gómez-Pardo M, Baiget |
Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study. Anticancer research 2011 Jan 31 (1): 359-66. Freyer Gilles, Duret Aude, Milano Gerard, Chatelut Etienne, Rebischung Christine, Delord Jean-Pierre, Merrouche Yacine, Lledo Gerard, Etienne Marie-Christine, Falandry Clai |
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. Cancer chemotherapy and pharmacology 2013 Jun 71 (6): 1463-72. Cortejoso Lucía, García María I, García-Alfonso Pilar, González-Haba Eva, Escolar Fernando, Sanjurjo María, López-Fernández Luis |
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer. The oncologist 2017 Feb . Kim Ji-Won, Lee Keun-Wook, Kim Kyu-Pyo, Lee Ju Hyun, Hong Yong Sang, Kim Jeong-Eun, Kim Sun Young, Park Sook Ryun, Nam Byung-Ho, Cho Sang-Hee, Chung Ik-Joo, Park Young Suk, Oh Ho-Suk, Lee Myung-Ah, Kang Hye Jin, Park Young Iee, Song Eun-Kee, Han Hye Sook, Lee Kyu Taeg, Shin Dong Bok, Kang Jung Hun, Zang Dae Young, Kim Jee Hyun, Kim Tae W |
Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity. British journal of clinical pharmacology 2018 Mar . Riera Pau, Salazar Juliana, Virgili Anna C, Tobeña María, Sebio Ana, Gallano Pía, Barnadas Agustí, Páez Dav |
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype. British journal of cancer 2019 Jan 120 (2): 190-195. Páez David, Tobeña María, Fernández-Plana Julen, Sebio Ana, Virgili Anna C, Cirera Lluís, Barnadas Agustí, Riera Pau, Sullivan Ivana, Salazar Julia |
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers. Therapeutic advances in medical oncology 2019 6 11 1758835919846421. Bruera Gemma, Massacese Silvia, Pepe Francesco, Malapelle Umberto, Dal Mas Antonella, Ciacco Eugenio, Calvisi Giuseppe, Troncone Giancarlo, Simmaco Maurizio, Ricevuto Enri |
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 2020 9 36 (1): 1-12. Koller Dora, Almenara Susana, Mejía Gina, Saiz-Rodríguez Miriam, Zubiaur Pablo, Román Manuel, Ochoa Dolores, Wojnicz Aneta, Martín Samuel, Romero-Palacián Daniel, Navares-Gómez Marcos, Abad-Santos Francis |
ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients. Frontiers in pharmacology 2020 7 11 973. Riera Pau, Artigas-Baleri Alícia, Salazar Juliana, Sebio Ana, Virgili Anna C, Arranz María Jesús, Páez Dav |
Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surgical oncology 2020 Sep 35 388-398. Puerta-García E, Urbano-Pérez D, Carrasco-Campos M I, Pérez-Ramírez C, Segura-Pérez A, Calleja-Hernández , Cañadas-Garre |
- Page last reviewed:Feb 1, 2024
- Content source: